Bacteriophage Company Reports Success With Expanded Access Program For Resistant Infections

Bacteriophage Company Reports Success With Expanded Access Program For Resistant Infections

Submitted by admin on September 17, 2018 - 9:55am
Source: 
CP Wire
News Tags: 
bacteriophage
Ampliphi Biosciences
AB-SA01
Headline: 
Bacteriophage Company Reports Success With Expanded Access Program For Resistant Infections
snippet: 

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced updated topline clinical results for its ongoing single-patient expanded access program.

Do Not Allow Advertisers to Use My Personal information